Terms: = Head and neck cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
78 results:
1. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
2. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
Young RJ; Angel C; Bressel M; Pizzolla A; Thai AA; Porceddu SV; Liu H; Idrizi R; Metta J; Lim AM; Solomon BJ; Rischin D
Oral Oncol; 2024 Mar; 150():106687. PubMed ID: 38262249
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma.
Bao J; Betzler AC; Hess J; Brunner C
Front Immunol; 2023; 14():1233085. PubMed ID: 37868967
[TBL] [Abstract] [Full Text] [Related]
6. Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures.
Li H; Lin WP; Zhang ZN; Sun ZJ
Acta Biomater; 2023 Dec; 172():1-15. PubMed ID: 37739247
[TBL] [Abstract] [Full Text] [Related]
7. Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
Nakamura S; Ohuchida K; Hayashi M; Katayama N; Tsutsumi C; Yamada Y; Hisano K; Okuda S; Ohtsubo Y; Iwamoto C; Torata N; Mizuuchi Y; Shindo K; Nakata K; Moriyama T; Morisaki T; Oda Y; Nakamura M
Br J Cancer; 2023 Oct; 129(8):1314-1326. PubMed ID: 37604932
[TBL] [Abstract] [Full Text] [Related]
8. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract] [Full Text] [Related]
10. A Wnt-induced lncRNA-DGCR5 splicing switch drives tumor-promoting inflammation in esophageal squamous cell carcinoma.
Li Y; Chen B; Jiang X; Li Y; Wang X; Huang S; Wu X; Xiao Y; Shi D; Huang X; He L; Chen X; Ouyang Y; Li J; Song L; Lin C
Cell Rep; 2023 Jun; 42(6):112542. PubMed ID: 37210725
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving head and neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
12. Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma.
Wen Z; Liu H; Qiao D; Chen H; Li L; Yang Z; Zhu C; Zeng Z; Chen Y; Liu L
ACS Nano; 2023 Apr; 17(8):7194-7206. PubMed ID: 37057967
[TBL] [Abstract] [Full Text] [Related]
13. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y
Br J Cancer; 2023 Jun; 128(12):2175-2185. PubMed ID: 37016103
[TBL] [Abstract] [Full Text] [Related]
14. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of multiple immune cells and patient outcomes in esophageal squamous cell carcinoma.
Wang H; Su C; Li Z; Ma C; Hong L; Li Z; Ma X; Xu Y; Wei X; Geng Y; Zhang W; Li P; Gu J
Front Immunol; 2023; 14():1091098. PubMed ID: 36891293
[TBL] [Abstract] [Full Text] [Related]
16. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
[TBL] [Abstract] [Full Text] [Related]
17. Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma.
Zhang B; Li H; Liu YT; Xiong D; Zhang L; Sun ZJ
Cancer Lett; 2023 Apr; 558():216105. PubMed ID: 36841416
[TBL] [Abstract] [Full Text] [Related]
18. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract] [Full Text] [Related]
19. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract] [Full Text] [Related]
20. High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.
Li H; Tang L; Han X; Zhong L; Gao W; Chen Y; Huang J; Wen Z
Ann Diagn Pathol; 2022 Dec; 61():152051. PubMed ID: 36272333
[TBL] [Abstract] [Full Text] [Related]
[Next]
